Results 201 to 210 of about 901,780 (213)

Targeted Therapy of Cancer: New Prospects for Antibodies and Immunoconjugates

Ca-A Cancer Journal for Clinicians, 2006
David M Goldenberg, R M Sharkey
exaly  

Antibody Engineering for the Development of Therapeutic Antibodies

Molecules and Cells, 2005
Sang Jick Kim
exaly  

The “less-is-more” in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity

MAbs, 2018
Zhiwei Song, Kah Fai Chan
exaly  

Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 1, monoclonal antibodies, antibody-drug conjugates and bispecific T-cell engagers

European Journal of Cancer, 2020
Angelo Paci, Olivier Mir
exaly  

Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans

Cell Reports, 2019
Lisa Smith, Kuan-Ying Huang, Stuart Dowall   +2 more
exaly  

Therapeutic Antibodies by Phage Display

Current Pharmaceutical Design, 2017
Hyunbo Shim
exaly  

Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?

Frontiers in Immunology, 2017
Michael Marshall, Richard James Stopforth, Mark Cragg   +2 more
exaly  

Therapeutic antibodies for autoimmunity and inflammation

Nature Reviews Immunology, 2010
Andrew Chan, Paul Carter, Chan Andrew C   +2 more
exaly  

Antibodies to glatiramer acetate do not interfere with its biological functions and therapeutic efficacy

Multiple Sclerosis Journal, 2003
Rina Aharoni, O Abramsky, D Teitelbaum   +2 more
exaly  

Characterization of glycosylation in monoclonal antibodies and its importance in therapeutic antibody development

Critical Reviews in Biotechnology, 2021
exaly